These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22482439)

  • 1. Quantitative analysis of microRNAs in tissue microarrays by in situ hybridization.
    Hanna JA; Wimberly H; Kumar S; Slack F; Agarwal S; Rimm DL
    Biotechniques; 2012 Apr; 52(4):235-45. PubMed ID: 22482439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In situ measurement of miR-205 in malignant melanoma tissue supports its role as a tumor suppressor microRNA.
    Hanna JA; Hahn L; Agarwal S; Rimm DL
    Lab Invest; 2012 Oct; 92(10):1390-7. PubMed ID: 22890556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and function of the miR-143/145 cluster in vitro and in vivo in human breast cancer.
    Johannessen C; Moi L; Kiselev Y; Pedersen MI; Dalen SM; Braaten T; Busund LT
    PLoS One; 2017; 12(10):e0186658. PubMed ID: 29073169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-specific detection of miR-375 downregulation for predicting the prognosis of esophageal squamous cell carcinoma by miRNA in situ hybridization.
    Li J; Li X; Li Y; Yang H; Wang L; Qin Y; Liu H; Fu L; Guan XY
    PLoS One; 2013; 8(1):e53582. PubMed ID: 23301089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer.
    Sempere LF; Christensen M; Silahtaroglu A; Bak M; Heath CV; Schwartz G; Wells W; Kauppinen S; Cole CN
    Cancer Res; 2007 Dec; 67(24):11612-20. PubMed ID: 18089790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcellular Localization of MicroRNAs by MicroRNA In Situ Hybridization (miR-ISH).
    Robinson HR; Hill MMC; Cristino AS
    Methods Mol Biol; 2019; 2054():159-169. PubMed ID: 31482455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy.
    Nakatani F; Ferracin M; Manara MC; Ventura S; Del Monaco V; Ferrari S; Alberghini M; Grilli A; Knuutila S; Schaefer KL; Mattia G; Negrini M; Picci P; Serra M; Scotlandi K
    J Pathol; 2012 Apr; 226(5):796-805. PubMed ID: 21960059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
    Wang B; Li J; Sun M; Sun L; Zhang X
    IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancer.
    Gravgaard KH; Lyng MB; Laenkholm AV; Søkilde R; Nielsen BS; Litman T; Ditzel HJ
    Breast Cancer Res Treat; 2012 Jul; 134(1):207-17. PubMed ID: 22294488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis.
    Zhang Y; Li M; Wang H; Fisher WE; Lin PH; Yao Q; Chen C
    World J Surg; 2009 Apr; 33(4):698-709. PubMed ID: 19030927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 4-microRNA signature predicts lymph node metastasis and prognosis in breast cancer.
    Chen X; Wang YW; Zhu WJ; Li Y; Liu L; Yin G; Gao P
    Hum Pathol; 2018 Jun; 76():122-132. PubMed ID: 29555574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of deregulated microRNAs in breast cancer progression using FFPE tissue.
    Chen L; Li Y; Fu Y; Peng J; Mo MH; Stamatakos M; Teal CB; Brem RF; Stojadinovic A; Grinkemeyer M; McCaffrey TA; Man YG; Fu SW
    PLoS One; 2013; 8(1):e54213. PubMed ID: 23372687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescence-based codetection with protein markers reveals distinct cellular compartments for altered MicroRNA expression in solid tumors.
    Sempere LF; Preis M; Yezefski T; Ouyang H; Suriawinata AA; Silahtaroglu A; Conejo-Garcia JR; Kauppinen S; Wells W; Korc M
    Clin Cancer Res; 2010 Aug; 16(16):4246-55. PubMed ID: 20682703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miRNA-34a is associated with docetaxel resistance in human breast cancer cells.
    Kastl L; Brown I; Schofield AC
    Breast Cancer Res Treat; 2012 Jan; 131(2):445-54. PubMed ID: 21399894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Observation of miRNA gene expression in zebrafish embryos by in situ hybridization to microRNA primary transcripts.
    He X; Yan YL; DeLaurier A; Postlethwait JH
    Zebrafish; 2011 Mar; 8(1):1-8. PubMed ID: 21288128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of the miR-17-92 cluster and miR-17 family in breast cancer according to tumor type; results from the Norwegian Women and Cancer (NOWAC) study.
    Moi L; Braaten T; Al-Shibli K; Lund E; Busund LR
    J Transl Med; 2019 Oct; 17(1):334. PubMed ID: 31581940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-187 is an independent prognostic factor in breast cancer and confers increased invasive potential in vitro.
    Mulrane L; Madden SF; Brennan DJ; Gremel G; McGee SF; McNally S; Martin F; Crown JP; Jirström K; Higgins DG; Gallagher WM; O'Connor DP
    Clin Cancer Res; 2012 Dec; 18(24):6702-13. PubMed ID: 23060431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progesterone receptor A promotes invasiveness and metastasis of luminal breast cancer by suppressing regulation of critical microRNAs by estrogen.
    McFall T; McKnight B; Rosati R; Kim S; Huang Y; Viola-Villegas N; Ratnam M
    J Biol Chem; 2018 Jan; 293(4):1163-1177. PubMed ID: 29162724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
    Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R
    Int J Cancer; 2013 Apr; 132(7):1633-45. PubMed ID: 22987275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of miRNA-9 and miRNA-34a as potential biomarkers for diagnosis of breast cancer in Iranian women.
    Orangi E; Motovali-Bashi M
    Gene; 2019 Mar; 687():272-279. PubMed ID: 30468908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.